(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-0.15%) $77.99
(0.37%) $2.15
(0.06%) $2 310.10
(0.36%) $26.79
(0.09%) $966.20
(-0.33%) $0.929
(-0.97%) $10.89
(-0.17%) $0.797
(0.52%) $91.61
Quarter results tomorrow
(bmo 2024-05-06)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck...
Stats | |
---|---|
Today's Volume | 10 908.00 |
Average Volume | 8 136.00 |
Market Cap | 10.04M |
EPS | $0 ( 2024-03-13 ) |
Next earnings date | ( $0 ) 2024-05-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.450 |
ATR14 | $0.0160 (0.86%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-26 | Cicala Peter | Buy | 88 946 | Stock Option (Right to buy) |
2024-04-26 | Gurrola Sandra M | Buy | 80 000 | Stock Option (Right to buy) |
2024-04-26 | Bristol James Arthur | Buy | 124 525 | Stock Option (Right to buy) |
2024-02-12 | Cicala Peter | Buy | 0 | |
2024-01-01 | Luther Sanjeev | Buy | 1 685 218 | Stock Option (right to buy) |
INSIDER POWER |
---|
66.27 |
Last 79 transactions |
Buy: 24 361 048 | Sell: 3 382 661 |
Eterna Therapeutics Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Eterna Therapeutics Inc. Financials
Annual | 2023 |
Revenue: | $68 000.00 |
Gross Profit: | $-1.29M (-1 898.53 %) |
EPS: | $-4.08 |
FY | 2023 |
Revenue: | $68 000.00 |
Gross Profit: | $-1.29M (-1 898.53 %) |
EPS: | $-4.08 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-497 000 (0.00 %) |
EPS: | $-8.06 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-56.40 |
Financial Reports:
No articles found.
Eterna Therapeutics Inc.
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators